EN
HI
Thyrocare Technologies Share price
THYROCARE
566.25
0.45 (-0.08%)NSE
BSE
Last updated on 21 Aug, 2026 | 13:18 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Thyrocare Technologies share price chart
Thyrocare Technologies Share Key Metrics
Volume
2.12 L
Market Cap
9019.90 CR
LTQ@LTP
4@566.25
ATP
567.18
Var Margin
75 %
Circuit Range
453.4-680
Delivery %
61.68 %
Value
12.01 CR
ASM/GSM
No
Market Lot
1
Summary
THYROCARE stock price is ₹566.25 as of 21 Aug, 2026. The stock intraday movement has stayed between ₹563.10 and ₹575.95, while Thyrocare Technologies share price 52 week high low is ₹342.55 & ₹662.00.
In terms of trading activity, THYROCARE share price has recorded a volume of 2,11,798 shares. The Thyrocare Technologies has a market cap of ₹159165315. The stock’s Average Traded Price (ATP) stands at ₹567.18, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 4 @ ₹566.25.
The Thyrocare Technologies upper circuit limit is ₹680.00 & The Thyrocare Technologies lower circuit limit is ₹453.40, with a Value of ₹12.01 CR. The Delivery Percentage for the day is 61.68%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Thyrocare Technologies Resistance and Support
Pivot 573.58
Resistance
First Resistance
583.11
Second Resistance
599.53
Third Resistance
609.06
Support
First Support
557.16
Second Support
547.63
Third Support
531.21
Thyrocare Technologies Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
60.93%
Mutual Fund
18.6%
Insurance
0.72%
Foreign Institutional Investors
4.96%
Domestic Institutional Investors
1.18%
Retail
13.61%
Others
0%
Total Promoters
MAR '25
71.06%
JUN '25
71.06%
SEP '25
71.06%
DEC '25
60.93%
Thyrocare Technologies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-14 | Qtr Results |
| 2025-07-23 | Quarterly Results |
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-06-23 | 2026-06-23 | View More |
| Bonus Date | Record Date | |
|---|---|---|
| 2025-10-14 | 2025-11-28 | View More |
Thyrocare Technologies News
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Thyrocare Technologies announced that 7.94 crore equity shares, representing 49.93% of its total share capital, have been released from pledge. This action was taken by Catalyst Trusteeship Limited on August 17, 2026, upon full repayment of Non-Convertible Debentures.
Aug 19 2026 11:00:22
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Docon Technologies, promoter of Thyrocare Technologies, announced the release of a pledge on 1.75 crore equity shares. This action reduces the total encumbered promoter holding from 60.92% to 49.93% of the company's total equity capital.
Aug 18 2026 11:18:06
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
HSBC Mutual Fund increased its stake in Thyrocare Technologies to 6.63% from 4.75%. The fund acquired an additional 1.88% stake through market purchases on August 13, 2026, crossing the 5% threshold.
Aug 18 2026 10:59:00
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Thyrocare Technologies' promoter, Docon Technologies, released a pledge on 1.75 crore equity shares. This reduces the promoter's total pledged holding from 60.92% to 49.93% of the company's equity.
Aug 18 2026 10:50:00
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Docon Technologies, Thyrocare's promoter, released pledge on 7.94 crore equity shares, constituting 49.93% of the company's total share capital. This action follows the full repayment of INR 10,500 million in NCDs by API Holdings Limited.
Aug 18 2026 10:06:37
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Thyrocare's promoter, Docon Technologies, announced the full release of pledge on 7.94 crore equity shares. This action, following the repayment of INR 10,500 million NCDs, removes all encumbrances on the promoter's shareholding.
Aug 17 2026 14:56:40
Thyrocare Technologies Ltd - 539871 - Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited
Thyrocare Technologies' promoter, Docon Technologies, released a pledge on 7.94 crore equity shares, representing 49.93% of the total share capital. This action follows the full repayment of Rs.1,050 crore Non-Convertible Debentures by API Holdings Limited.
Aug 17 2026 14:21:47
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund sold 3,36,110 shares of Thyrocare Technologies on August 12, 2026. This open market transaction reduced its stake from 5.33% to 3.27%, a net decrease of 2.06% in the company's paid-up capital.
Aug 14 2026 12:17:16
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Thyrocare Technologies reported the release of a pledge on 1.75 crore equity shares. This action decreased the total encumbered shares from 60.92% to 49.93% of the company's voting capital, indicating a deleveraging by the pledgor, Docon Technologies Private Limited.
Aug 14 2026 11:16:00
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Thyrocare Technologies' promoter, Docon Technologies Private Limited, announced the release of a pledge on 1.75 crore equity shares. This reduces the total encumbered shares from 60.92% to 49.93% of the company's equity capital.
Aug 13 2026 11:04:33
Read More
Thyrocare Technologies Management
| Name | Position |
|---|---|
| Brijesh Kumar | Company Secretary & Compliance Officer |
| Rahul Guha | Chairman, Managing Director & Chief Executive Officer |
Thyrocare Technologies Similar Stocks
Blue Jet Healthcare Ltd.
594.50
-0.80 (0.13%)
Healthcare Global Enterprises Ltd.
726.15
-4.30 (0.59%)
Jupiter Life Line Hospitals Ltd.
313.90
-3.80 (1.20%)
Suven Life Sciences Ltd.
368.90
-4.70 (1.26%)
Strides Pharma Science Ltd.
991.50
-1.50 (0.15%)
Procter & Gamble Health Ltd.
5840.00
7.50 (0.13%)
Yatharth Hospital & Trauma Care Services Ltd.
849.70
1.85 (0.22%)
Aarti Pharmalabs Ltd.
824.00
-5.25 (0.63%)
Sanofi India Ltd.
3355.70
34.70 (1.04%)
Thyrocare Technologies FAQs
The Buying Price of Thyrocare Technologies share is 566.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Thyrocare Technologies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Thyrocare Technologies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Thyrocare Technologies shares is 51.21. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Thyrocare Technologies shares is 14.34. Useful to assess the stock's value relative to its book value.
To assess Thyrocare Technologies’s valuation compare Sector P/E, P/B which are 48.36 & -14.22 with sector averages, along with growth rates and financial metrics.
The Market Cap of Thyrocare Technologies is 9019.90 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Thyrocare Technologies share price is 662.00 & 342.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Thyrocare Technologies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in THYROCARE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC